Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Novartis
Harvard Business School
Express Scripts
Chubb
Healthtrust
Deloitte
Moodys
Cerilliant
Farmers Insurance

Generated: October 20, 2017

DrugPatentWatch Database Preview

Tentative Approvals for: Hetero Labs Unit Iii

« Back to Dashboard
Applicant Generic Name NDA Strength Dosage Form
Hetero Labs Unit Iii
maraviroc
203347150MGTABLET;ORAL
Hetero Labs Unit Iii
emtricitabine; tenofovir disoproxil fumarate
201806200MG; 300MGTABLET; ORAL
Hetero Labs Unit Iii
darunavir ethanolate
202083150MGTABLET;ORAL
Hetero Labs Unit Iii
ritonavir
204587100MGTABLET;ORAL
Hetero Labs Unit Iii
darunavir ethanolate
202083300MGTABLET;ORAL
Hetero Labs Unit Iii
darunavir ethanolate
202083600MGTABLET;ORAL
Hetero Labs Unit Iii
maraviroc
203347300MGTABLET;ORAL
Hetero Labs Unit Iii
darunavir ethanolate
202083400MGTABLET;ORAL
Hetero Labs Unit Iii
lamivudine; nevirapine; zidovudine
202157150MG; 200MG; 300MGTABLET; ORAL
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Fuji
Fish and Richardson
Farmers Insurance
Cantor Fitzgerald
Argus Health
McKinsey
Cerilliant
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot